Humana (HUM) Receives Hold Rating from Cantor Fitzgerald

Humana (NYSE:HUM)‘s stock had its “hold” rating reaffirmed by Cantor Fitzgerald in a research report issued to clients and investors on Tuesday. They presently have a $230.00 target price on the insurance provider’s stock. Cantor Fitzgerald’s price objective indicates a potential downside of 9.21% from the stock’s previous close.

HUM has been the topic of several other research reports. BMO Capital Markets raised their price target on Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a research note on Friday, November 10th. Royal Bank Of Canada restated a “sector perform” rating and set a $242.00 price target (down previously from $245.00) on shares of Humana in a research note on Thursday, November 9th. Deutsche Bank raised their price target on Humana from $234.00 to $243.00 and gave the company a “hold” rating in a research note on Monday, August 7th. BidaskClub lowered Humana from a “hold” rating to a “sell” rating in a research note on Thursday, August 17th. Finally, ValuEngine lowered Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Twelve investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $255.80.

Humana (NYSE HUM) traded up $1.06 during mid-day trading on Tuesday, reaching $253.34. The company’s stock had a trading volume of 927,700 shares, compared to its average volume of 1,384,502. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.61 and a current ratio of 1.61. Humana has a twelve month low of $186.25 and a twelve month high of $264.56. The stock has a market capitalization of $36,040.74, a price-to-earnings ratio of 21.53, a price-to-earnings-growth ratio of 1.73 and a beta of 0.88.

Humana (NYSE:HUM) last released its earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, topping analysts’ consensus estimates of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The business had revenue of $13.28 billion for the quarter, compared to analyst estimates of $13.41 billion. During the same quarter last year, the firm posted $3.18 earnings per share. The business’s revenue was down 3.0% compared to the same quarter last year. equities research analysts forecast that Humana will post 11.63 earnings per share for the current fiscal year.

A number of hedge funds have recently modified their holdings of the stock. WFG Advisors LP boosted its position in Humana by 4.5% during the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock valued at $113,000 after purchasing an additional 20 shares in the last quarter. Cadence Capital Management LLC boosted its position in Humana by 0.4% during the second quarter. Cadence Capital Management LLC now owns 5,682 shares of the insurance provider’s stock valued at $1,367,000 after purchasing an additional 22 shares in the last quarter. Financial Advisors Network Inc. boosted its holdings in Humana by 3.4% in the second quarter. Financial Advisors Network Inc. now owns 1,413 shares of the insurance provider’s stock worth $340,000 after acquiring an additional 46 shares in the last quarter. HL Financial Services LLC boosted its holdings in Humana by 0.9% in the second quarter. HL Financial Services LLC now owns 7,963 shares of the insurance provider’s stock worth $1,916,000 after acquiring an additional 68 shares in the last quarter. Finally, Nordea Investment Management AB boosted its holdings in Humana by 1.0% in the second quarter. Nordea Investment Management AB now owns 7,338 shares of the insurance provider’s stock worth $1,766,000 after acquiring an additional 74 shares in the last quarter. 94.19% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Humana (HUM) Receives Hold Rating from Cantor Fitzgerald” was reported by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.com-unik.info/2017/12/06/humana-hum-receives-hold-rating-from-cantor-fitzgerald.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Analyst Recommendations for Humana (NYSE:HUM)

What are top analysts saying about Humana Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Humana Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit